Wuxi Jida Pharmaceutical Co., Ltd.

Company Description



In 2005, Jida Group set up Wuxi Jida (WXJD) in Jiangsu, long a leading area for chemical synthesis and pharmaceutical industry in the PRC, as Wuxi Jida Pharmaceutical Co., Ltd. manufacturing base of the Pharmaceutical Bulk Material (APIs) and novel pharmaceutical intermediates.

We are targeting to develop into a major international APIs manufacturer, producing sophisticated APIs worldwide including USA and EU countries. Some of the product has already reached the international standard and with DMFs submitted to the FDA. Our plant has state-of-art production technologies, with exceptional emphasis being put on safety, health and environment.

WXJD has rich experience in the manufacturing, R&D and management of pharmaceutical APIs and we have well defined functional departments including R&D, QA & QC and Regulatory. By virtue of our outstanding technical capabilities, meticulous quality management system and flexible production capacity, WXJD will definitely be your ideal partner for contract manufacturing.

Company Information

Product

  • Citalopram Hydrobromide
  • Risperidone
Countries   China   India   Indonesia   Malaysia   Pakistan   Turkey   United Kingdom   United States   All Countries